Diversified Healthcare TrustDHC +2.52%56 EBITDA Margin % is 15.62% as of Mar. 2026, which is 56% below its 10-year median of 35.24. GuruFocus rates DHC with a GF Score™ of 56/100 and a GF Value™ of $3.20 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 750 REITs companies, Diversified Healthcare Trust ranks worse than 90.4% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Diversified Healthcare Trust EBITDA Margin % Related Terms
Diversified Healthcare Trust EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Diversified Healthcare Trust's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diversified Healthcare Trust EBITDA Margin % vs REITs Industry
For the REITs industry and Real Estate sector, Diversified Healthcare Trust's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Diversified Healthcare Trust's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diversified Healthcare Trust (DHC) has a EBITDA Margin % of 15.62% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Diversified Healthcare Trust and its competitors. This is 56% below median its historical median of 35.24. Over the past decade, Diversified Healthcare Trust's EBITDA Margin % has ranged from 5.79 to 67.84. According to the industry distribution chart, Diversified Healthcare Trust ranks #678 out of 750 companies in the REITs industry, placing it in the top 90.4%.
Is Diversified Healthcare Trust's EBITDA Margin % too high?
Diversified Healthcare Trust's current EBITDA Margin % of 15.62% is 56% below median its 10-year median of 35.24. Over the past 10 years, this metric has ranged from a low of 5.79 to a high of 67.84. The REITs industry median EBITDA Margin % is 69.61. Diversified Healthcare Trust's value of 15.62% is 77.6% below this industry median. Based on the distribution chart, Diversified Healthcare Trust ranks #678 out of 750 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Diversified Healthcare Trust has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diversified Healthcare Trust's EBITDA Margin % compare to LTC and SILA?
According to the REITs industry distribution chart, Diversified Healthcare Trust ranks #678 out of 750 companies for EBITDA Margin %. This places Diversified Healthcare Trust in the lower half of its industry. The industry median EBITDA Margin % is 69.61. Diversified Healthcare Trust's value of 15.62% is 77.6% below this benchmark. Historically, Diversified Healthcare Trust's own EBITDA Margin % has ranged from 5.79 to 67.84 over the past decade. While the company's 10-year median is 35.24 vs. the industry median of 69.61, Diversified Healthcare Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.61, based on 750 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diversified Healthcare Trust's current EBITDA Margin % of 15.62% is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Diversified Healthcare Trust and its competitors. For the REITs industry, the median EBITDA Margin % is 69.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diversified Healthcare Trust's current EBITDA Margin % is 15.62%, which is 56% below median its own 10-year median of 35.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diversified Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, Diversified Healthcare Trust (DHC) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.20, compared to a current price of $9.37 — trading 192.8% above its estimated fair value. The current EBITDA Margin % is 15.62%, which is 56% below median its 10-year median of 35.24 and 77.6% below the REITs industry median of 69.61. Diversified Healthcare Trust's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Diversified Healthcare Trust (DHC), the current EBITDA Margin % is 15.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diversified Healthcare Trust (DHC) Overvalued in 2026?
Based on GuruFocus' analysis, Diversified Healthcare Trust stock appears to be overvalued.
The current stock price of $9.37 is trading 192.8% above its estimated GF Value™ of $3.20.
GuruFocus considers Diversified Healthcare Trust to be Significantly Overvalued.
Key valuation signals for DHC:
EBITDA Margin %: 15.62% (56% below median its 10-year median of 35.24)
GF Value™: $3.20 vs. price of $9.37 (192.8% above fair value)
Industry Position: 77.6% below the REITs median (#678 of 750)
No single metric tells the full story. See the DHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
56GF Score
Get the complete analysis for DHC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHC has been successfully added to your 
